Home

GlucoTrack, Inc. - Common Stock (GCTK)

7.7800
-2.8100 (-26.53%)
NASDAQ · Last Trade: Sep 15th, 9:56 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close10.59
Open8.690
Bid8.020
Ask8.060
Day's Range7.200 - 8.880
52 Week Range4.220 - 3,576.00
Volume1,076,285
Market Cap7.00M
PE Ratio (TTM)0.0986
EPS (TTM)78.9
Dividend & YieldN/A (N/A)
1 Month Average Volume4,072,847

Chart

About GlucoTrack, Inc. - Common Stock (GCTK)

GlucoTrack, Inc. is a healthcare technology company focused on the development of innovative non-invasive glucose monitoring solutions for individuals with diabetes. The company leverages advanced sensing technologies to create devices that enable users to track their blood glucose levels without the need for traditional fingerstick methods. GlucoTrack aims to improve the quality of life for diabetic patients by providing them with more convenient and accessible ways to manage their condition, while also enabling healthcare providers to better monitor patient health. Through its commitment to research and development, GlucoTrack seeks to contribute to more effective diabetes management and enhance overall patient outcomes. Read More

News & Press Releases

Here are the top movers in Monday's session.chartmill.com
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · September 15, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · September 15, 2025
Which stocks are moving on Monday?chartmill.com
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · September 15, 2025
Glucotrack Stock Just Rose Over 123% Today: Here’s An Important Updatestocktwits.com
Via Stocktwits · September 12, 2025
Monday's session: gap up and gap down stockschartmill.com
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · September 15, 2025
Monday's pre-market session: top gainers and loserschartmill.com
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · September 15, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 15, 2025
New Mountain Finance, Texas Instruments, Analog Devices And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 15, 2025
Why Check-Cap Shares Are Trading Higher By 183%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · September 15, 2025
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · September 12, 2025
These stocks are moving in today's after hours sessionchartmill.com
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · September 12, 2025
Which stocks are experiencing notable movement on Friday?chartmill.com
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · September 12, 2025
Dow Dips 200 Points; US Consumer Sentiment Falls In Septemberbenzinga.com
Via Benzinga · September 12, 2025
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · September 12, 2025
Keep an eye on the top gainers and losers in Friday's session.chartmill.com
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · September 12, 2025
Which stocks are gapping on Friday?chartmill.com
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · September 12, 2025
US Stocks Mixed; Adobe Posts Upbeat Q3 Resultsbenzinga.com
Via Benzinga · September 12, 2025
Top movers in Friday's pre-market sessionchartmill.com
The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · September 12, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 12, 2025
Glucotrack to Participate in the Q3 Virtual Investor Summit
RUTHERFORD, N.J., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that management will present and participate in one-on-one meetings with investors at the Q3 Virtual Investor Summit, being held on September 16-17, 2025.
By Glucotrack, Inc. · Via GlobeNewswire · September 11, 2025
There are notable gap-ups and gap-downs in today's session.chartmill.com
The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · September 2, 2025
Tuesday's pre-market session: top gainers and loserschartmill.com
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · September 2, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 2, 2025
Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · September 2, 2025
Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology
Experienced cardiac electrophysiologist joins Glucotrack’s growing clinical advisory team as the Company advances its long-term CBGM through critical clinical milestones
By Glucotrack, Inc. · Via GlobeNewswire · August 6, 2025